FDA Accepts sBLA for Genentech’s Gazyva in Lupus Nephritis
Gazyva is the only anti-CD20 monoclonal antibody in a randomized Phase III study to demonstrate a complete renal response benefit The filing application is based...
Category : Healthcare and Pharmaceutical
TEVIMBRA Approved for First-Line ESCC Treatment with Chemo
New indication based on results from a global Phase 3 trial demonstrating significantly improved overall survival benefit for PD-L1 positive patients treated with TEVIMBRA in...
Orbis Medicines Appoints Mikael Dolsten as Board Chair
Orbis Medicines, a leader in oral macrocycle drug discovery, today announces the appointment of Mikael Dolsten, M.D., Ph.D., former Chief Scientific Officer, President, Pfizer Research...
SFI Health™ EMEA Launches Equazen® Food Supplements in Portugal
Partner Eqyon Healthcare Solutions will market Equazen® products featuring a clinically researched combination of essential fatty acids in pharmacies and parapharmacies. SFI Health™ EMEA, the...
Purdue-led panel to explore pharmaceutical transformations
President Mung Chiang joins industry leaders during SXSW to discuss the university’s role in shaping the future of pharma Purdue University’s position as a key...
Assembly Biosciences Doses First Participant in ABI-6250 Study
Phase 1a study will evaluate single and multiple ascending doses of ABI-6250 in healthy participants with data expected in Q3 2025 Biomarker of ABI-6250 target...
YMCA and DaVita collaborate to enhance kidney health in 7 areas
YMCA of the USA (Y-USA), the national resource office for the 2,600+ YMCAs across the country, is excited to expand its collaboration with DaVita, a leading...
Philips expands cloud imaging services in Europe for AI workflows
Accelerating cloud adoption across Europe with Philips HealthSuite Imaging cloud services on Amazon Web Services Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health...
SimCare AI raises $2M to scale clinical training with AI
SimCare AI, founded by two University of Chicago dropouts, has secured $2 million in seed funding to expand its AI-driven healthcare simulation platform. The company’s...
Avirmax Begins IND Studies for ABI-201 Gene Therapy for AMD
Avirmax Biopharma, Inc., a leader in developing the next generation of AAV gene therapies, today announced the commencement of Investigational New Drug (IND)-enabling studies of...
METiS Pharmaceuticals Appoints Mark Herbert as Chief Business Officer
METiS Pharmaceuticals, a clinical-stage, AI-driven biotechnology company specializing in innovative drug delivery technologies, today announced the appointment of Mark Herbert as Chief Business Officer (CBO), effective January 22,...
Validic Launches AI-Powered Health IoT Solutions on AWS
Validic, a leader in healthcare technology innovation, announced today that its full suite of Intelligent Digital Care Solutions and Services will soon be available in...
Xolair Shows Greater Efficacy, Fewer Side Effects than OIT
First-ever head-to-head trial comparing Xolair and oral immunotherapy (OIT) Results were featured as late-breakers at the 2025 AAAAI Annual Meeting Xolair is the only U.S....
Identiv and Novanta Partner to Simplify RFID Adoption for Healthcare
Identiv and Novanta to market new RFID-based solutions that fill much needed gap for medical device and pharmaceutical manufacturers. Novanta Inc., a global technology supplier to...
The Future of Medicine: VoxCell BioInnovation on All Access
All Access with Andy Garcia explores how VoxCell BioInnovation Inc. is revolutionizing drug development with 3D bioprinting, paving the way for personalized medicine and an end to...